Introduction
============

Transthyretin (TTR), also known as prealbumin is a 55 kDa homo-tetrameric protein found in plasma and cerebrospinal fluid. It consists of four identical subunits, with each subunit consisting of 127 amino acid residues ([@B24]; [@B29]). TTR structure is rich in β-sheets with four binding sites; two for thyroxine and two for retinol-RBP complex ([@B27]; [@B43]). It is encoded by a 7 kb gene (comprising of four exon and three introns) located at chromosome 18q11.2-- q12.1 ([@B69]; [@B63]). It is primarily responsible for the transport of thyroxin and retinol-retinol binding complex (RBP-complex) to different parts of the body and brain ([@B51]; [@B47]). The major site of serum TTR synthesis is liver with normal concentration in the range of 0.2--0.4 mg/ml and half-life of 2 days. In central nervous system, TTR is expressed in choroid plexus and is released into the cerebrospinal fluid with concentration in the range of 0.02--0.04 mg/ml ([@B60]). In addition to plasma and cerebrospinal fluid, it is also expressed in the endothelial cells of Islets of Langerhans, retinal and ciliary pigment epithelia in trace amounts ([@B10]; [@B31]; [@B72]). TTR may also undergo oligomerization and such TTR oligomers are specifically picked up by cardiomyocytes, neuronal and kidney cells leading to organ malfunctions ([@B12]). Deficiency of the normal function of TTR has been known to be associated with obesity and diabetes ([@B74]). The roles of TTR in the central nervous system, especially in cognition and memory, psychological health and emotion have also been widely understood ([@B19]; [@B6]). The oligomeric form of the TTR has been found to be involved in the pathophysiology of various diseases including atherosclerosis, familial amyloidosis polyneuropathy ([@B13]), senile systemic amyloidosis ([@B73]), familial amyloidosis cardiomyopathy ([@B28]; [@B75]; [@B54]) etc. Although main function of transthyretin is the transport of thyroxine and retinol bound to retinol binding protein (RBP), there are many other biological roles of TTR that are directly or indirectly related to anti-oxidant and oxidant properties and could be an important oxidative stress biomarker or therapeutic target. For instance, (i) TTR level correlates well with reactive oxygen species (ROS) or reactive nitrogen species (RNS) ([@B53]; [@B20]); (ii) TTR gene expression is regulated by stress hormone, glucocorticoid and sex hormone, estradiol ([@B34]; [@B40]); (iii) Even though TTR is an extracellular protein, it can induce oxidative stress in endoplasmic stress (ER) and hence involved in unfolded protein response (UPR) ([@B66]; [@B21]; [@B11]); (iv) The oligomeric forms of TTR also plays an important role in inducing oxidative stress and could be involved in different pathophysiologies ([@B26]; [@B78]). In the light of these observations, this review article has been designed to discuss that TTR is associated with oxidative stress and has implications for potential disease specific biomarker.

TTR is a Neuronal Stress Biomarker
==================================

It has already been understood that oxidative stress is one primary cause of Alzheimer's disease (AD) and many other neurodegenerative diseases ([@B39]). Recent advances have unveiled that such a cause of oxidative stress has a good correlation with the role of TTR. This is evident from various studies. First, TTR level is upregulated in patients with neurodegenerative disorders ([@B34]) wherein oxidative stress is the common cause of the pathophysiology. Because quantitative real time PCR of TTR mRNA and western blot analysis, have shown that primary neurons from AD mice exhibit upregulation of TTR level as compared to non-demented age-matched individuals or control mice ([@B34]). Second, TTR expression is directly regulated by sex hormones (e.g., estradiol) or stress hormones (e.g., glucocorticoids) in neuronal cells ([@B40]). For instance, when rat choroid plexus and choroid plexus epithelial cell lines were incubated with varying concentration of hydrocortisone and estradiol (E2) (0, 10, 100, or 1,000 nM) for 6, 12, 18, 24 and 36 h ([@B40]), there was increase in TTR protein and TTR mRNA levels in a concentration dependent manner of the hormones. Similarly, incubation of the cells with respective receptor antagonists results in the suppression of TTR induction. In another experiment, they also analyzed the level of corticosterone in liver, choroid plexus and cerebrospinal fluid of adult rats in response to chronic and acute stress. Stress was induced by increasing the animal density. It was observed that the given treatments drive the upregulation of expression of TTR. In another development, based on *in silico* study, [@B70] demonstrated that rat TTR gene contains a glucocorticoid-responsive element in its 3′ region of the first intron ([@B70]) and this element is conserved in humans as well ([@B56]). Thus, it was concluded that upregulation of TTR expression by glucocorticoid treatments is *via* glucocorticoid-responsive element. Taken together, the results indicate that TTR has a close association with the level of oxidative stress and hence might consequently contribute to the pathogenicity of neurodegeneration.

Third, other studies also reported that TTR has the ability to suppress or remove β-amyloid deposits from neuronal tissues ([@B8]) making TTR a crucial target for the therapeutic intervention of AD. In fact, direct evidence of the involvement of TTR in AD stems from the identification of physical interaction between TTR and Aβ ([@B23]). Mechanistically, TTR present in the cerebrospinal fluid could sequesters β-amyloid and inhibits the oligomerization and plaque formation ([@B57]). It is believed that TTR uses its cryptic protease activity to proteolyze Aβ into smaller non-amyloidogenic fragments ([@B14]; [@B59]). In another development, recent study further revealed that TTR has higher affinity to Aβ aggregates rather than the fibrils and bind to these pre-toxic aggregates in a chaperon-like manner in both the extracellular and intracellular environment ([@B8]). It has also been understood the higher the binding affinity between TTR and Aβ, the higher is the inhibitory potential because stabilizers that increase TTR tetramer stability augments the inhibitory effect ([@B14]; [@B52]). Similarly, few TTR mutants that is more stable than the Wt TTR has been shown to exhibit more disaggregating potential than Wt TTR ([@B14]).

It has been known that major cytotoxicity of deposition of β-amyloid is oxidative stress ([@B7]). Since there exists a good correlation between oxidative stress and TTR expression, we speculate that oxidative stress induces glucocorticoids which in turn increase TTR expression via its action on the glucocorticoid receptors. The increased level of TTR will further help to deal with the β-amyloid deposits bringing about its role in preventing AD ([@B44]). In addition to AD, there are a large number of neuronal disorders due to oxidative stresses. These include psychological (e.g., depression), movement disorder (e.g., Parkinson), cognitive disorders etc. Therefore, possibility of the association between these diseases and TTR level may be exploited as a potential biomarker (or therapeutic target) for such disorders.

Cryptic Protease Activity of Transthyretin Induces Oxidative Stress by Cleaving Apo A-1
=======================================================================================

High-density lipoprotein (HDL) complex is responsible for reverse cholesterol efflux and cholesterol transport from cells and tissues back to liver ([@B25]). Besides cholesterol efflux, HDL also exhibit anti-oxidant activity by forming complex with many anti-oxidant enzymes like paraoxonase, platelet-activating factor acetylhydrolase, glutathione peroxidase, lipid transfer proteins like lecithin: cholesterol acyl transferase, cholesterol ester transfer protein, Apolipoprotein A-I (ApoA-I) and 1-palmitoyl-2-oleoyl-phosphatidylcholine. Among these anti-oxidant enzymes, Apo A-I is the major anti-oxidant and anti-inflammatory component associated with HDL ([@B42]). It employs anti-oxidant activity by eliminating lipid hydroperoxides from low-density lipoproteins (LDL) and anti-inflammatory properties by shutting down the expression of adhesion molecules ([@B42]).

One important protein that affects the anti-oxidant property of HDL is the serum protein, TTR 1-2% of serum TTR is associated with HDL molecules ([@B61]). As mentioned above, TTR transports thyroxine and retinol bound to RBP. In the absence of retinol-RBP complex, TTR occasionally exhibit its cryptic protease function ([@B36]). This activity of TTR brings about specific cleavage of Apo A-I resulting in the loss of anti-oxidant function of HDL ([@B37]; [@B46]). Figure [1](#F1){ref-type="fig"} illustrates the mechanism of how TTR acts to cleave the Apo A-1. Immunologically, the proteolyzed product of Apo A-I acts as a pro-inflammatory molecule that further adds in oxidative stress ([@B42]). In another development, both the proteolyzed product of apo A-I i.e. N-terminal and C-terminal domains are observed to be amyloidogenic ([@B16]). Since, amyloids or proteins aggregates are one important basic cause of oxidative stress ([@B1]), the formation of the amyloidogenic species will further augment the magnitude of the oxidative stress.

![Cryptic protease activity of TTR and cleavage of Apo A-I. **(A)** HDL complex associated with the antioxidant enzymes. **(B)** TTR protein bound to thyroxine and retinol-RBP complex. **(C)** HDL complex with TTR. TTR exhibits no cryptic protease activity until it is bound to retinol-RBP complex. **(D)** Cryptic protease activity of TTR when retinol-RBP complex is not bound, Apo A-I is cleaved into N and C-terminal. HDL, high density lipoprotein; PON1, paraoxonase; POPC, 1-palmitoyl-2-oleoyl-phosphatidylcholine; RBP, retinol binding protein; TTR, transthyretin.](fphys-10-00005-g001){#F1}

Interestingly, Sousa and his group (2004) recently reported that the cryptic protease activity of TTR was seen only when RBP-retinol complex was not bound to TTR ([@B36]) (Figure [1](#F1){ref-type="fig"}). This indicates that such type of oxidative stress (due to cryptic protease activity of TTR) may perhaps be related to the retinol deficiency and hence diseases associated with it ([@B4]). Therefore, the protease activity of TTR can be a potential biomarker for oxidative stress as well as for diseases associated with retinol deficiency. Furthermore Apo-A I deficiency (due to the cleavage by TTR) make HDL unable to remove cholesterol from the tissues. This will eventually result in the atherosclerotic plaque formation. Thus TTR cryptic protease activity and associated oxidative stress may further by employed as a biomarker for cardiovascular disorders.

TTR is Glutathionylated
=======================

Glutathiol (GSH) is a low molecular weight thiol group present in all the cells and serum. GSH also acts as a good indicator of cellular redox state and anti-oxidant defence ([@B15]). The antioxidant property of GSH is mediated by glutathione peroxidase as it oxidizes GSH to GSSG thereby reducing hydrogen peroxide and lipid hydroperoxides ([@B68]). Protein-glutathionylation is a redox-mediated post-translational modification, which involves conjugation of a glutathione with a cysteine thiol group on the proteins ([@B22]). Glutathionylation not only plays a critical role in many important biological functions (regulation of metabolic pathways, calcium homeostasis, signal transduction, cytoskeleton remodeling, inflammation and protein folding) but also is involved in oxidative stress ([@B30]). The involvement in oxidative stress may stem from at least in two viewpoints. Large scale adduct formation with cysteine group in proteins will eventually lead to deficiency of GSH levels making the system difficult to handle the oxidative stress. Alternatively, once GSH has been bound to cysteine residues in proteins, there is release of free electron ([@B22]) that consequently help to generate free radicals thereby inducing oxidative stress. Interestingly, TTR has been reported to be glutathionylated under certain conditions. This was revealed from a study conducted by Ando and his group (1998) to determine the *in vivo* behavior of transthyretin in blood using electrospray ionization mass spectrometry analysis coupled with high-pressure liquid chromatography (HPLC) ([@B67]). Purified TTR from normal subjects was injected into the rats and after 3 h, blood and the urine were analyzed by measuring free or modified TTR. Lower level of free TTR in blood and no TTR secretion into the urine were observed ([@B67]) indicating that major fraction of TTR have been modified by glutathione. Inside the cell, glutathionylation is not restricted to TTR alone but also occurs to many other proteins, the results indicate that TTR indeed contributes to the oxidative stress generated due to protein glutathionylation.

[@B18] reported that the levels of glutathionylated form of TTR are inversely correlated in patients with Mycosis fungoides (MF) or non-Hodgkin's lymphoma ([@B18]). It is worth noting that MF is associated with the genetic polymorphism in genes involved in the regulation of oxidative stress ([@B35]). The results hint that the development of MF is because of oxidative stress originated through genetic or post-translational modifications. Therefore, the glutathionylated forms of TTR may be a potential biomarker for early diagnosis or therapeutic target for MF.

TTR Oligomers as Multiple Biomarkers
====================================

It has been well understood that dissociation of TTR oligomer is the rate-limiting step to TTR amyloidosis because dissociation results in the exposition of important sites for oligomerization ([@B12]; [@B62]). Similarly, mutations in TTR disrupt its tetramer and thus form toxic oligomers ([@B26]). The toxic TTR oligomers are believed to preferentially deposit in the extracellular matrix (ECM) of hepatocytes or neuronal cells leading to the development of familial amyloidosis, which encompass FAP (Familial Amyloid Polyneuropathy) ([@B5]; [@B55]) and FAC (Familial Amyloid Cardiomyopathy) ([@B13]). Mechanistically, large deposition of such TTR oligomers in the cardiac and neuronal cells results in the tissue injury that ultimately lead to the increase in inflammatory response ([@B79]). Since oligomers are known to induce oxidative stress in cells and inflammatory response is going to add more impact on oxidative stress, accumulation of the oligomers eventually results in organ failure or tissue damage due to massive oxidative stress. Although in general oligomers are the exact cause or consequences of such oxidative stress is not clearly understood, it is certainly possible that a positive feedback loop is formed wherein oxidation causes more oligomerization of TTR, which in turn causes more TTR oxidation. In addition to cardiomyopathy and polyneuropathy, this feedback loop so formed (in case of TTR oligomers), may affect following consequences as outlined in Figure [2](#F2){ref-type="fig"} leading to involvement of TTR in different pathophysiologies or various biological processes. Following sections will describe the involvement of TTR oligomers in each of the consequences.

![TTR oligomers are linked with various pathophysiological consequences.](fphys-10-00005-g002){#F2}

TTR Oligomer Is Related to Reactive Nitrogen Species
----------------------------------------------------

In addition to the ROS like superoxide radicals, hydrogen peroxide etc., (RNS) including nitrate and nitrite ions also plays a major role in oxidative stress. [@B20] gave the first evidence for the increased production of RNS in presence of TTR aggregates in two different human cell lines, epidermoid (A431) and schwannoma (sNF94.3) ([@B20]). Moreover, the authors also observed that the cells treated with TTR aggregates showed decreased metabolic activities as compared to TTR non-treated cells ([@B20]). This indicates that the RNS-induced pro-oxidative effects could also hamper the metabolic activity of the cells. In a previous study by [@B53], it was established that Wt and V30M (amyloidogenic variant) undergoes S-nitrosylation and due to which the proteins become amyloidogenic ([@B53]). Nitric oxide is generated in vessels from endothelial cells and smooth muscle cells. Vessels are the primary site for deposition of protein oligomers, therefore the nitrosylation of the TTR oligomers further enhances the ability to form amyloid fibrils which further contributes to the increased oxidative damage and *vice versa*. Since, there is a close correlation between TTR level and RNS or ROS, determination of TTR oligomeric level may help to evaluate the extent/magnitude of oxidative stress.

TTR Oligomers Can Be Used to Detect Endoplasmic Reticulum (ER) Stress
---------------------------------------------------------------------

When there is increased generation of misfolded or unfolded proteins in the ER, UPR initiates ([@B66]; [@B71]). This UPR is mediated by three signal pathways which involves inositol-requiring enzyme 1, activating transcription factor 6 and double-stranded RNA-activated protein kinase-like ER kinase ([@B71]; [@B41]; [@B50], [@B49]). Since TTR is an extracellular protein and it is unlikely that it may be involved in UPR generation in the ER. However, when TTR oligomers are deposited in neuronal cells, cardiomyocytes and kidney cells, there are chances that the misfolded species or TTR oligomers reach ER and cause oxidative stress. In a systemic study by [@B66] the role of TTR oligomers in ER stress response was investigated using TTR transgenic mouse, and cell lines models ([@B66]). It was established that there was increased levels of BiP-immunoglobulin binding protein (an ER-resident chaperone) with extracellular TTR amyloid deposits in the brain of transgenic mouse. Furthermore using mouse neuronal ND7 cell line, it was also observed that oligomer-induced increased expression of BiP was mediated by the release of calcium from ER to cytosol ([@B66]). Because the activity of Caspases-3 was observed in cells treated with only TTR oligomers and not in cells treated with dantrolene and xestospongin (inhibitors of Ca^2+^ release). The involvement of other secondary messengers like D-myo inositol 1,4,5-triphosphate which receives signals at plasma membrane suggests that extracellular TTR oligomers have the potential to trigger ER stress in the surrounding cells. Taken together, the results convincingly supported the premise that the deposited TTR oligomers in tissues helps to induce UPR in the ER ([@B58]). Since TTR is a serum protein and is not present in ER, the study links the possibility of invoking UPR in ER by other extracellular proteins.

Level of TTR Aggregates Negatively Correlates With the Activity of Catalase
---------------------------------------------------------------------------

Amyloid deposits consist of proteinaceous fibers which keep on depositing in tissues and form plaques. In case of AD, it was observed that these amyloid deposits had a toxic effect on cells as the cells showed apoptosis both *in vitro* and *in vivo*. [@B2] performed an *in vitro* study with different cell lines like neuroblastoma cell lines, PC12 cells, HeLa cells and some haematopoietic cell lines to investigate for the toxic effect of aggregated mutant TTR ([@B2]). It was observed that the toxic effect was not cell specific and further it triggered the signaling cascade which ultimately led to apoptosis ([@B38]). Interestingly, it has been shown that TTR induced apoptosis was inhibited by catalase in a concentration-dependent manner. Since catalase is an enzyme responsible for catalyzing H~2~O~2~ which is a predominant ROS, the results suggest that TTR oligomer-induced apoptosis is via production of H~2~O~2~ or other ROS.

Oligomers of Different TTR Variants Exhibit Different Magnitude of Oxidative Stress
-----------------------------------------------------------------------------------

Protein oligomerization or amyloidogenesis has been considered to be one common hallmark of oxidative stress ([@B17]). In fact, these protein oligomers are really toxic to the cells and can affect the integrity and hence function of various cell organelles ([@B76]). It is also believed that protein oligomers elevate the production of ROS which causes the oxidative stress and *vice versa* causing cell damage ([@B77]). Protein oligomers can also force the release and normal function of Cytochrome C by directly affecting mitochondrial potential ([@B9]) or by affecting other pro-apoptotic molecules ([@B45]). Despite these developments, how different protein oligomers (or generated by different variants) could associate with the magnitude of proteotoxicity has not been explored yet. In this connection, TTR oligomers represents an emblemic signature as oligomers generated by different variants, is related to time of onset of disease pathology and hence determines the nature of proteotoxicity or oxidative stress ([@B48]; [@B64]). For instance, Wt TTR oligomerization that leads to systemic senile amyloidosis was apparent in older individuals at the age of around 60--70 ([@B78]). On the other hand, the pathogenic symptoms due to oligomers of the mutant variant V122I appeared early in age and patients die generally 10 years before the onset of senile systemic cardiomyopathy caused by Wt aggregation. The onset of familial amyloid polyneuropathy caused by the variant, V30M is around 25--33 years and death occurs 10 years after the onset ([@B32]; [@B65]; [@B3]). L55P is considered to be most pathogenic variant of TTR and starts oligomerization at the physiological pH *in vitro* (as compared to the other mutants) and patients die at a very young age ([@B33]; [@B26]). Not only mutant variants, but Wt TTR has also been reported to undergo oxidation and carbonylation whose proteotoxicities (and hence oxidative stress) matches with the age of individuals. Thus, identification of different variants of TTR may be employed as a biomarker for the age related oxidative stress. Future research should focus on identification of newer TTR variants and their related onset of diseases or magnitude of oxidative stress.

Summary and Future Perspectives
===============================

It is clearly evident from this review that different activity or post-translational modification of TTR is linked to specific disease pathologies *via* oxidative stress. The potential of TTR to cause oxidative stress is not only confined to serum, but also in ER. Therefore, in-depth insights to the various mechanism of oxidative stress induced by TTR and its oligomers will eventually lead to appropriate therapeutic strategies for these specific diseases. It is also understood that TTR oligomers can invoke different signaling cascades leading to different biological consequences (e.g., apoptosis, ROS and RNS generation, UPR and redox mediated oxidation) resulting in oxidative stress. It would therefore be important to explore the signaling cascade in detail by which oligomers help to induce such multiple consequences. Nevertheless TTR would be a potential biomarker of several human diseases linked with oxidative stress.
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